Loading
Loading
Review of Case Materials
Reviews records, documents, testimony, data, and other relevant materials and consults with counsel regarding technical issues related to the matter.
Provide Expert Analysis
Applies specialized knowledge and experience to evaluate the technical or professional issues involved.
Form Expert Opinions
Develops independent, supportable opinions based on the available evidence and relevant standards.
Prepare Expert Reports
Showing Results 0 of 0
In current SAMHSA guidance, opiates refers more specifically to naturally occurring substances derived from the opium poppy, including morphine and codeine. Opioids is the broader category and includes opiates as well as semisynthetic and synthetic drugs such as oxycodone, hydrocodone, heroin, and fentanyl. That distinction matters when selecting an expert because the particular substance, testing method, and disputed scientific question should determine the appropriate expertise rather than using the terms interchangeably.
Some prescription opioids overlap directly with opiate evidence. Morphine and codeine, for example, are naturally occurring opiates and may be prescribed medically. Other prescription opioids, including oxycodone and hydrocodone, fall within the broader opioid category rather than the narrower definition of opiates. CDC identifies morphine alongside hydrocodone and oxycodone as examples of prescription opioids. When prescription opioids are part of the case, the specific drug and disputed scientific question should guide the scope of analysis. Prescription history, dose, timing, administration records, metabolites, and laboratory findings may all affect how the evidence is interpreted.
The analysis may involve specimen type, collection and handling, screening procedures, confirmatory testing, reported analytes, cutoff concentrations, metabolites, quality-control documentation, and chain of custody. The HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs identify specified opioid analytes and cutoff concentrations and provide requirements for initial and confirmatory testing of covered federal agency specimens. These details can matter when determining whether a laboratory finding reliably identifies the substance at issue and what conclusions can reasonably be drawn from that result.
A laboratory-confirmed positive result indicates that the tested substance or metabolite was identified in the specimen under the applicable analytical criteria, such as a specified confirmatory cutoff. In federal workplace-testing programs, a laboratory-confirmed positive result is subject to Medical Review Officer review and verification. A positive analytical result does not by itself establish impairment, overdose, causation, or the effect of the drug at a particular time. Those conclusions may depend on specimen type, concentration, timing, metabolism, tolerance, other substances, medical history, and the circumstances of the event. When those physiological or causal questions become central, Toxicology or other clinical expertise may be needed. NIJ describes forensic toxicology as the analysis and interpretation of drugs in biological samples, including consideration of concentrations and their potential relationship to illness, death, or impairment.
Prepares clear, well-supported expert reports outlining methodology, analysis, findings, and opinions.
Provide Deposition Testimony
Explains findings and opinions under oath and responds to questioning during deposition testimony.
Testify in Court
Presents specialized findings and opinions clearly to judges, juries, arbitrators, or other decision-makers.